As we observe World Lung Day, it is crucial to reflect on the escalating impact of respiratory diseases across the globe. Chronic respiratory diseases — including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary hypertension, obstructive sleep apnea, and others — continue to rank among the leading causes of morbidity and mortality worldwide. The World Health Organization’s latest data underscores the persistence of the global respiratory crisis:
Leading experts discuss the role of different inflammatory pathways in COPD disease progression.
Watch a short video presentation on the diagnosis and assessment of COPD according to the 2024 GOLD report, focusing on clinical features and assessment goals. Then join leading experts as they discuss the latest advances in understanding COPD, originally presented by Sanofi and Regeneron Pharmaceuticals in two symposia at ERS 2023 and GOLD 2023.
World Tuberculosis (TB) Day is observed annually on 24 March to raise awareness about tuberculosis and to commemorate the discovery of the Mycobacterium tuberculosis bacterium (M.tb) by Dr Robert Koch in 1882. It aims to educate people about the impact of ...
Prof. Tony Mok discusses the role of KRAS mutations in solid tumours and the impact of KRASG12C inhibitors on patient outcomes.
Watch a panel of experts discuss challenges in the diagnosis of CRSwNP and considerations for optimal management of the disease.
Select a discussion in the hub to watch our multidisciplinary faculty share their insights on biomarker testing methods and interpretation of results to guide treatment selection for a patient with advanced NSCLC.
Watch a panel of experts discuss how to identify and manage patients with inflammatory respiratory diseases, with a focus on severe eosinophilic asthma.
Watch a panel of experts discuss immunotherapy for non-small cell lung cancer (NSCLC) and the possible future role of interleukin-1β (IL-1β) blockade.
Watch Dr Enrico Heffler describe how eosinophilic inflammation can be targeted for the treatment of inflammatory respiratory diseases.
Watch leading non-small cell lung cancer (NSCLC) experts discuss immunotherapy and the emerging approaches targeting interleukin-1 (IL-1).
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also ...
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.